Sort
15,842 grants matching “pancreatic cancer”
Evaluating the mechanism by which the DYNLL1-MRE11 complex regulates DNA end resection and genome stability.
$74,284Michelle Swift · Dana-Farber Cancer Inst · F32 · FY2024 · GM
Diversificiation of MUC1 Function by Alternate Splicing in Pancreatic Cancer
$74,250Michael A Hollingsworth · University Of Nebraska Medical Center · R03 · FY2009 · CA
Epigenetic therapy with 3-deazaneplanocin A and gemcitabine for pancreatic cancer
$74,250Rajgopal Govindarajan · University Of Georgia · R03 · FY2012 · CA
MUC1 regulation of TGF-beta function in pancreatic cancer cells
$74,250Pinku Mukherjee · University Of North Carolina Charlotte · R03 · FY2013 · CA
Diversificiation of MUC1 Function by Alternate Splicing in Pancreatic Cancer
$74,250Michael A Hollingsworth · University Of Nebraska Medical Center · R03 · FY2008 · CA
A novel combination therapy for the treatment of Pancreatic adenocarcinoma
$74,250Michael A Hollingsworth · University Of Nebraska Medical Center · R03 · FY2012 · CA
Role of Nucleostemin in Conferring The Drug Resistance of Hepatocellular Carcinoma
$74,250Robert Y Tsai · Texas A&M University Health Science Ctr · R03 · FY2016 · CA
Epigenetic therapy with 3-deazaneplanocin A and gemcitabine for pancreatic cancer
$74,250Rajgopal Govindarajan · University Of Georgia · R03 · FY2011 · CA
EGFRvIII in Pancreatic Cancer
$74,250Maneesh Jain · University Of Nebraska Medical Center · R03 · FY2010 · CA
ETV4 in pancreatic cancer
$74,250Seema Singh · University Of South Alabama · R03 · FY2012 · CA
Effect of Beta-secretase Inhibitors on Pancreatic Cancer Cells
$74,250Joyce C Solheim · University Of Nebraska Medical Center · R03 · FY2012 · CA
Functional assessment of methylation-associted nuclear proteins in pancreatic ade
$74,250Talal Elhefnawy · University Of Pittsburgh At Pittsburgh · R03 · FY2008 · CA
Chemical Biology Approach to Myeloma &Pancreatic Cancer
$74,250Northwestern University · U56 · FY2004 · CA
EGFRvIII in Pancreatic Cancer
$74,250Maneesh Jain · University Of Nebraska Medical Center · R03 · FY2009 · CA
A novel combination therapy for the treatment of Pancreatic adenocarcinoma
$74,250Michael A Hollingsworth · University Of Nebraska Medical Center · R03 · FY2011 · CA
Functional assessment of methylation-associted nuclear proteins in pancreatic ade
$74,250Talal Elhefnawy · University Of Pittsburgh At Pittsburgh · R03 · FY2007 · CA
Role of Nucleostemin in Conferring The Drug Resistance of Hepatocellular Carcinoma
$74,250Robert Y Tsai · Texas A&M University Health Science Ctr · R03 · FY2017 · CA
Role of GSK-3 isoforms in Pancreatic Cancer
$74,250Muthusamy Kunnimalaiyaan · University Of Wisconsin-Madison · R03 · FY2011 · CA
Flt3L Treatment of Pancreatic Cancer
$74,250Joyce C Solheim · University Of Nebraska Medical Center · R03 · FY2013 · CA
Mechanisms of met-Induced Hepatocytes Survival
$74,250Reza Zarnegar · University Of Pittsburgh At Pittsburgh · R01 · FY2007 · CA
MicroRNAs in Pancreatic Cancer
$74,188Ajay Pratap Singh · University Of South Alabama · R03 · FY2010 · CA
NADPH oxidase and pancreatic cancer cell survival
$74,160Anna S Gukovskaya · Brentwood Biomedical Research Institute · R01 · FY2006 · CA
Targeting cancer stem cell initiation during pancreatic cancer development
$74,000Altaf Mohammed · University Of Oklahoma Hlth Sciences Ctr · R03 · FY2014 · CA
Hedgehog-mediated survival mechanisms in pancreatic cancer
$74,000Martin Ernesto Fernandez-Zapico · Mayo Clinic Rochester · R03 · FY2006 · CA
Targeting cancer stem cell initiation during pancreatic cancer development
$74,000Naveena B Janakiram · University Of Oklahoma Hlth Sciences Ctr · R03 · FY2015 · CA